13 September 2022 - Rymti is Lupin’s biosimilar etanercept approved for all indications of the reference product. ...
13 September 2022 - Approval is based on the Phase 3 KEYNOTE-716 trial. ...
9 September 2022 - Health Canada approves Pfizer-BioNTech COVID-19 vaccine for kids under 5. ...
7 September 2022 - Novel mechanism of action of Pluvicto binds to target PSMA positive cancer cells, delivering radiation treatment directly ...
1 September 2022 - Today, Health Canada authorised an adapted version of the Moderna Spikevax COVID-19 vaccine. ...
23 August 2022 - First and only immunotherapy-based treatment for use before surgery for non-small-cell lung cancer in Canada. ...
19 August 2022 - The 10 mcg dose can be given at least 6 months after primary series is completed. ...
16 August 2022 - Launch of Korsuva in Canada is expected in the second quarter of 2023. ...
11 August 2022 - First and only approved medicine targeting germline BRCA mutations in high-risk early breast cancer. ...
8 August 2022 - Paladin Labs announced today that Health Canada has accepted its new drug submission for cenobamate tablets as ...
21 July 2022 - Prevnar 20 is the first conjugate vaccine indicated to help protect against 20 serotypes responsible for ...
20 July 2022 - Approval is supported by efficacy and safety data of two pivotal studies in which Rinvoq demonstrated improvements ...
14 July 2022 - Today, Health Canada authorised the use of the Moderna Spikevax COVID-19 vaccine in children 6 months to ...
11 July 2022 - Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical studies, as ...
6 July 2022 - Canadian regulatory submission acceptance follows that of the US FDA and the EMA as well as ...